Trial Profile
A prospective trial evaluated the efficacy and safety of mesenchymal stem cell therapy along with neural stem cell therapy in patients with diabetic retinopathy and diabetic optic neuropathy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Mar 2016
Price :
$35
*
At a glance
- Drugs Mesenchymal stem cell therapy (Primary) ; Neural stem cell therapy (Primary)
- Indications Diabetic retinopathy
- Focus Therapeutic Use
- 29 Mar 2016 New trial record